Department of Genetics (MBC-03), King Faisal Specialist Hospital and Research Centre, P.O. Box 3354, Riyadh 11211, Saudi Arabia.
J Clin Endocrinol Metab. 2010 Mar;95(3):1000-6. doi: 10.1210/jc.2009-1823. Epub 2010 Jan 20.
Dyshormonogenesis due to genetic defect in thyroglobulin (Tg) synthesis and secretion can lead to congenital hypothyroidism.
The aim of the study was to analyze the TG gene for the presence of mutations and to study the underlying mechanisms leading to dyshormonogenesis.
Two siblings aged 25 and 31 yr presented with recurrent goitrous hypothyroidism with undetectable serum Tg. The older sibling was diagnosed with follicular variant of papillary thyroid carcinoma (FVPTC) at age 21 and metastatic FVPTC 8 yr later.
The entire coding region of TG gene was sequenced. BRAF, RAS, and P53 mutations or PAX8/PPAR-gamma rearrangement were screened in the FVPTC. Tg expression was studied by immunohistochemistry.
Biallelic c.6725G>A (p.R2223H) and c.6396C>T (p.S2113L) sequence variations were detected in both patients and monoallelic variations in their family members. The c.6396C>T (p.S2113L) sequence variation was found in 14% of 100 population controls, whereas c.6725G>A variation was not present in the controls. Two previously reported polymorphisms (c.2200T>G and c.3082A>G) were present in all the family members. Strong cytoplasmic immunostaining of Tg was observed in the hyperplastic thyroid epithelial cells and weak or no staining in the follicular lumen. Cytoplasmic staining was localized in the endoplasmic reticulum. Reduced staining was found in the FVPTC. Neither RAS, BRAF, or P53 gene mutation nor a PAX8/PPAR-gamma rearrangement was detected in the tumor tissue.
Biallelic c.6725G>A (p.R2223H) mutation causes Tg retention in the endoplasmic reticulum, resulting in dyshormonogenesis. Prolonged TSH stimulation may promote malignant transformation and development of thyroid cancer. The c.6396C>T (p.S2113L) is a novel polymorphism.
由于甲状腺球蛋白(Tg)合成和分泌的遗传缺陷导致的激素生成障碍可导致先天性甲状腺功能减退症。
本研究的目的是分析 Tg 基因是否存在突变,并研究导致激素生成障碍的潜在机制。
两名年龄分别为 25 岁和 31 岁的同胞均表现为复发性结节性甲状腺功能减退症,血清 Tg 无法检测到。年长的同胞在 21 岁时被诊断为滤泡状甲状腺癌(FVPTC),8 年后转移为 FVPTC。
对 TG 基因的整个编码区进行测序。在 FVPTC 中筛选 BRAF、RAS 和 P53 突变或 PAX8/PPAR-γ重排。通过免疫组织化学研究 Tg 表达。
在两名患者及其家族成员中均检测到双等位基因 c.6725G>A(p.R2223H)和 c.6396C>T(p.S2113L)序列变异,而其家族成员则存在单等位基因变异。c.6396C>T(p.S2113L)序列变异在 100 名人群对照者中的发生率为 14%,而 c.6725G>A 变异在对照者中不存在。所有家族成员均存在两个先前报道的多态性(c.2200T>G 和 c.3082A>G)。在增生的甲状腺上皮细胞中观察到 Tg 的强细胞质免疫染色,而在滤泡腔内则为弱染色或无染色。细胞质染色定位于内质网。在 FVPTC 中发现染色减少。在肿瘤组织中未检测到 RAS、BRAF 或 P53 基因突变,也未检测到 PAX8/PPAR-γ重排。
双等位基因 c.6725G>A(p.R2223H)突变导致 Tg 在内质网中滞留,导致激素生成障碍。延长 TSH 刺激可能促进甲状腺癌的恶性转化和发展。c.6396C>T(p.S2113L)是一种新的多态性。